Global, regional, and national burden of liver cancer attributable to high BMI and hyperglycemia from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021

To quantify the global, regional, and national burden of liver cancer attributable to high body mass index (BMI) and hyperglycemia from 1990 to 2021 using Global Burden of Disease (GBD) 2021 data, we analyzed GBD 2021 estimates for 204 countries and territories, 21 GBD regions, and 5 Sociodemographic Index (SDI) quintiles. Attributable deaths and disability-adjusted life years (DALYs) were estimated using population attributable fractions. Temporal trends were assessed using estimated annual percentage changes (EAPCs), together with age-period-cohort, SDI, frontier, decomposition, and inequality analyses. From 1990 to 2021, global deaths attributable to high BMI increased from 10,282 (95% uncertainty interval [UI], 4196-16,722) to 46,204 (95% UI, 18,606-77,983), while the age-standardized mortality rate (ASMR) increased from 0.26 to 0.53 per 1,00,000 population. The EAPCs for high BMI were 2.37 (95% confidence interval [CI], 2.29-2.45) for ASMR and 2.31 (95% CI, 2.22-2.40) for the age-standardized DALY rate (ASDR). For hyperglycemia, the corresponding EAPCs were 1.90 (95% CI, 1.74-2.05) and 1.65 (95% CI, 1.51-1.79). The fastest increases occurred in South Asia for high BMI and Southern Latin America for hyperglycemia. The burden was generally higher among males and older adults, with substantial geographic and socioeconomic heterogeneity. The liver cancer burden attributable to high BMI and hyperglycemia increased substantially from 1990 to 2021. Integrated metabolic risk reduction and liver cancer prevention strategies are needed, particularly in populations experiencing rapid increases in metabolic risk.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051341
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Global, regional, and national burden of liver cancer attributable to high BMI and hyperglycemia from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021

Wanshuang Zhou, Zhuo Liu, Yanping Lu, Xin Yang
9 links
Medicine
Cancer Risks and Factors
article

Global, regional, and national burden of liver cancer attributable to high BMI and hyperglycemia from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021

Wanshuang Zhou, Zhuo Liu, Yanping Lu, Xin Yang
article en

Abstract

To quantify the global, regional, and national burden of liver cancer attributable to high body mass index (BMI) and hyperglycemia from 1990 to 2021 using Global Burden of Disease (GBD) 2021 data, we analyzed GBD 2021 estimates for 204 countries and territories, 21 GBD regions, and 5 Sociodemographic Index (SDI) quintiles. Attributable deaths and disability-adjusted life years (DALYs) were estimated using population attributable fractions. Temporal trends were assessed using estimated annual percentage changes (EAPCs), together with age-period-cohort, SDI, frontier, decomposition, and inequality analyses. From 1990 to 2021, global deaths attributable to high BMI increased from 10,282 (95% uncertainty interval [UI], 4196-16,722) to 46,204 (95% UI, 18,606-77,983), while the age-standardized mortality rate (ASMR) increased from 0.26 to 0.53 per 1,00,000 population. The EAPCs for high BMI were 2.37 (95% confidence interval [CI], 2.29-2.45) for ASMR and 2.31 (95% CI, 2.22-2.40) for the age-standardized DALY rate (ASDR). For hyperglycemia, the corresponding EAPCs were 1.90 (95% CI, 1.74-2.05) and 1.65 (95% CI, 1.51-1.79). The fastest increases occurred in South Asia for high BMI and Southern Latin America for hyperglycemia. The burden was generally higher among males and older adults, with substantial geographic and socioeconomic heterogeneity. The liver cancer burden attributable to high BMI and hyperglycemia increased substantially from 1990 to 2021. Integrated metabolic risk reduction and liver cancer prevention strategies are needed, particularly in populations experiencing rapid increases in metabolic risk.

MedicineVol. 105(46)
Changsha Medical University (CN), Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine) (CN), Hunan Traditional Chinese Medical College (CN)
Good health and well-being
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon